Pharmacokinetics of melatonin in preterm infants

Perinatal pharmacology: Applications for neonatal neurology

(2011) Anne Smits et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Two-year neurodevelopmental outcome of preterm born children

(2010) M. J. Claas et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

A structured review of the recent literature on the economic consequences of preterm birth

(2010) S. Petrou et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

Early-Childhood Neurodevelopmental Outcomes Are Not Improving for Infants Born at

(2010) S. R. Hintz et al.   PEDIATRICS

Socio-economic achievements of individuals born very preterm at the age of 27 to 29 years: a nationwide cohort study

(2009) RENÉ MATHIASEN et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Outcomes at Age 2 Years of Infants < 28 Weeks' Gestational Age Born in Victoria in 2005

(2009) Lex W. Doyle et al.   JOURNAL OF PEDIATRICS

Melatonin Promotes Oligodendroglial Maturation of Injured White Matter in Neonatal Rats

(2009) Paul Olivier et al.   PLoS One

Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin

(2008) Eloisa Gitto et al.   JOURNAL OF PINEAL RESEARCH